OtherTOXICOLOGY
Sulindac Metabolism and Synergy with Tumor Necrosis Factor-α in a Drug-Inflammation Interaction Model of Idiosyncratic Liver Injury
Wei Zou, Kevin M. Beggs, Erica M. Sparkenbaugh, A. Daniel Jones, Husam S. Younis, Robert A. Roth and Patricia E. Ganey
Journal of Pharmacology and Experimental Therapeutics October 2009, 331 (1) 114-121; DOI: https://doi.org/10.1124/jpet.109.156331
Wei Zou
Kevin M. Beggs
Erica M. Sparkenbaugh
A. Daniel Jones
Husam S. Younis
Robert A. Roth
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherTOXICOLOGY
Sulindac Metabolism and Synergy with Tumor Necrosis Factor-α in a Drug-Inflammation Interaction Model of Idiosyncratic Liver Injury
Wei Zou, Kevin M. Beggs, Erica M. Sparkenbaugh, A. Daniel Jones, Husam S. Younis, Robert A. Roth and Patricia E. Ganey
Journal of Pharmacology and Experimental Therapeutics October 1, 2009, 331 (1) 114-121; DOI: https://doi.org/10.1124/jpet.109.156331
OtherTOXICOLOGY
Sulindac Metabolism and Synergy with Tumor Necrosis Factor-α in a Drug-Inflammation Interaction Model of Idiosyncratic Liver Injury
Wei Zou, Kevin M. Beggs, Erica M. Sparkenbaugh, A. Daniel Jones, Husam S. Younis, Robert A. Roth and Patricia E. Ganey
Journal of Pharmacology and Experimental Therapeutics October 1, 2009, 331 (1) 114-121; DOI: https://doi.org/10.1124/jpet.109.156331
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement